MAP4K4 INHIBITORS

This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There ar...

Full description

Saved in:
Bibliographic Details
Main Authors JARVIS, Ashley, MARTIN, Nicholas, PERRIOR, Trevor, LOW, Caroline, NEWTON, Gary, REISINGER, Tifelle, NEGOITA-GIRAS, Gabriel, BAYFORD, Melanie, FISHER, Martin, CHAPMAN, Nicholas, AQIL, Rehan, FIEDLER, Lorna R, CHAPMAN, Katie, SCHNEIDER, Michael
Format Patent
LanguageEnglish
Published 20.06.2024
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).
Bibliography:Application Number: US202318459937